Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
256,606,920
-
Number of holders
-
920
-
Total 13F shares, excl. options
-
230,800,835
-
Shares change
-
-1,015,787
-
Total reported value, excl. options
-
$41,840,598,359
-
Value change
-
-$222,800,189
-
Put/Call ratio
-
1.08%
-
Number of buys
-
441
-
Number of sells
-
-466
-
Price
-
$181.39
Significant Holders of VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) as of Q3 2021
1,106 filings reported holding VRTX - VERTEX PHARMACEUTICALS INC / MA - Common Stock as of Q3 2021.
VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) has 920 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 230,800,835 shares
of 256,606,920 outstanding shares and own 89.94% of the company stock.
Largest 10 shareholders include BlackRock Inc. (23,547,895 shares), VANGUARD GROUP INC (20,442,691 shares), STATE STREET CORP (12,323,416 shares), Capital World Investors (11,042,302 shares), ALLIANCEBERNSTEIN L.P. (9,068,848 shares), LOOMIS SAYLES & CO L P (7,005,992 shares), WELLINGTON MANAGEMENT GROUP LLP (6,091,089 shares), PRICE T ROWE ASSOCIATES INC /MD/ (5,698,247 shares), Clearbridge Investments, LLC (5,112,404 shares), and FMR LLC (4,877,098 shares).
This table shows the top 920 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.